All you need to know about Godhra train burning case

Agencies
October 9, 2017

New Delhi, Oct 9: The Gujarat high court is likely to pronounce its verdict on a set of appeals challenging convictions and acquittals by a Special Investigation Team court in the 2002 Godhra train burning case on Monday, more than two years after the completion of hearings on the matter.

The judgement will be delivered by a bench of justice Anant Dave and justice GR Udhwani at about 11am.

Here’s all you need to know about the case:

Train set on fire

A coach of the Sabarmati Express was set on fire at Godhra on February 27, 2002. The blaze in S6 coach killed 59 Hindus, mostly karsevaks or volunteers returning from Ayodhya, where rival Hindu and Muslim groups are locked in a decades-old dispute over a religious site.

The train fire sparked three days of reprisal attacks across the state that left 790 Muslims and 254 Hindus dead, official sources say. And as many as 100,000 Muslims and 40,000 Hindus were rendered homeless in the riots. About 130 are still reported missing.

Probe into the carnage

The Nanavati Commission, appointed by the Gujarat government to probe the incident, concluded that the fire in the coach was not an accident but it was set on fire. The Sangh Parivar claimed the train fire was targeted at the Hindus, who were returning to Ayodhya after a pilgrimage.

A damning report of Mohinder Singh Dahiya, the then assistant director of Gandhinagar’s Forensic Studies Laboratory (FSL), concluded that the coach was set afire by someone “standing in the passage of the compartment near seat number 72, using a container with a wide opening about 60 litres of inflammable liquid has been poured and then a fire has been started in the bogie”.

The accused

The special SIT court on March 1, 2011, convicted 31 people and acquitted 63 in the case. While 11 people were sentenced to death, 20 were handed out life imprisonment.

The court convicted 31 people while accepting the prosecution’s contention that there was a conspiracy behind the incident.

All the 31 were convicted under various sections of the Indian Penal Code related to murder, attempt to murder and criminal conspiracy. Those acquitted included prime accused Maulana Umarji, the then president of Godhra municipality Mohammad Hussain Kalota, Mohammad Ansari and Nanumiya Chaudhary of Gangapur, Uttar Pradesh.

Later, several appeals were filed in the high court challenging the convictions, while the Gujarat government questioned the acquittal of the 63 people.

The 2002 Gujarat riots

There were SIT probes into the involvement of several political leaders, including Prime Minister Narendra Modi - who was then the Gujarat chief minister - for criminal conspiracy in the riots. Modi and others were cleared after the SIT filed a closure report on February 8, 2012.

Maya Kodnani, the women and child welfare minister in the then Modi government in Gujarat, was sentenced to life in prison for a separate case of rioting in Ahmedabad’s Naroda Patiya area, a verdict she has challenged. She has been on bail since 2014.

Comments

Althaf
 - 
Monday, 9 Oct 2017

When court is controlling by sangh parivar then what verdict we can expect ?? All verdict will be in favor of sangh parivar.

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 21,2020

New Delhi, Mar 21: Novel coronavirus cases in India rose to 258 on Saturday after 35 fresh cases were reported in various parts of the country, according to the Health Ministry.

Among the 258 are 39 foreign nationals, including 17 from Italy, three from the Philippines, two from the UK, one each belonging to Canada, Indonesia and Singapore.

The total figure also includes four deaths reported from Delhi, Karnataka, Punjab and Maharashtra.

"The total number of active COVID-19 cases across India stands at 231 so far," the ministry said, adding that 23 others have been cured/discharged/migrated while four have died.

Delhi has, so far, reported 26 positive cases, which include one foreigner, while Uttar Pradesh has recorded 24 cases, including one foreigner.

Maharashtra has 52 cases, including three foreigners, while Kerala has recorded 40 cases, which include seven foreign nationals.

Karnataka has 15 coronavirus patients. The number of cases in Ladakh rose to 13 and Jammu & Kashmir four. Telangana has reported 19 cases, which include 11 foreigners.

Rajasthan has also reported 17 cases, including two foreigners. Gujarat has reported seven cases so far.

Tamil Nadu, Andhra Pradesh and Uttarakhand have reported three cases each.

West Bengal, Odisha and Punjab each reported two cases while Puducherry, Chhattisgarh and Chandigarh reported one case each.

In Haryana, there are 17 cases, which include 14 foreigners.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
January 27,2020

New Delhi, Jan 27: The government on Monday issued the preliminary information memorandum for 100 per cent stake sale in national carrier Air India. As part of the strategic disinvestment, Air India would also sell 100 per cent stake in low cost airline Air India Express and 50 per cent shareholding in joint venture AISATS, as per the bid document issued on Monday.

Management control of the airline would also be transferred to the successful bidder.

The government has set March 17 as the deadline for submitting the Expression of Interest (EoI).

EY is the transaction adviser for Air India disinvestment process.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 30,2020

Hyderabad, Jun 30: Hyderabad-based Bharat Biotech announced that it has successfully developed Covaxin, India's first vaccine candidate for Covid-19, in collaboration with the Indian Council of Medical Research (ICMR) and National Institute of Virology (NIV).

The Drug Controller General of India - CDSCO, Ministry of Health & Family Welfare granted permission to initiate Phase I & II Human clinical trials after the company submitted results generated from preclinical studies, demonstrating safety and immune response. Human clinical trials are scheduled to start across India in July 2020.

The SARS-CoV-2 strain was isolated in NIV, Pune and transferred to Bharat Biotech.

The indigenous, inactivated vaccine developed and manufactured in the company's Bio-Safety Level 3 (BSL-3) High Containment facility located in Genome Valley, Hyderabad.

Announcing the vaccine development milestone, Dr Krishna Ella, Chairman and Managing Director said: "We are proud to announce COVAXIN, India's first indigenous vaccine against COVID-19. The collaboration with ICMR and NIV was instrumental in the development of this vaccine."

Dr Ella added, "The proactive support and guidance from CDSCO has enabled approvals to this project. Our R&D and Manufacturing teams worked tirelessly to deploy our proprietary technologies towards this platform."
Expedited through national regulatory protocols, the company accelerated its objective in completing the comprehensive pre-clinical studies. Results from these studies have been promising and show extensive safety and effective immune responses.

Speaking about Bharat Biotech's prowess, Suchitra Ella, Joint Managing Director said, "Our ongoing research and expertise in forecasting epidemics has enabled us to successfully manufacture a vaccine for the H1N1 pandemic."
"Continuing our focus on creating the only BSL-3 containment facilities for manufacturing and testing in India, Bharat Biotech is committed to advancing vaccine development as a matter of national importance to demonstrate India's strength in handling future pandemics," she added.

Bharat Biotech's track record in developing vero cell culture platform technologies has been proven in several vaccines for Polio, Rabies, Rotavirus, Japanese Encephalitis, Chikungunya and Zika.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.